EGFR and head and neck squamous cell carcinoma: We further demonstrated that PEG significantly reduced the expression of Cyclin D1, a downstream effector of EGFR that is overexpressed in HNSCC [21] and involved in causing resistance to therapeutic drugs such as cisplatin [22] and gefitinib [23].